Superworth

Nuwellis EPS NUWE

Diluted earnings per share by quarter and over the last twelve months, from 2011.

Last 12 months, to Jun 30, 2026
−$136.54
Latest quarter, Q2 FY26
−$26.64
Fiscal year 2025
−$3179.99

Nuwellis' earnings per share was −$136.54 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$26.64.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3179.99n/a
FY2024−$61239.15n/a
FY2023−$692796.30n/a
FY2022−$6424047.00n/a
FY2021−$18007500.00n/a
FY2020−$91838250.00n/a
FY2019−$2505975150.00n/a
FY2018−$6950380500.00n/a
FY2016−$1060699374000.00n/a
FY2015−$1905913800000.00n/a
FY2014−$1970740800000.00n/a
FY2013−$2217083400000.00n/a
FY2012−$2593080000000.00n/a
FY2011−$3811827600000.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$26.64n/a−$136.54
Q1 FY26−$76.65n/a−$2244.09
Q4 FY25−$52.85n/a−$3179.99
Q3 FY25$19.60−99%−$3773.94
Q2 FY25−$2134.19n/a−$1230.49
Q1 FY25−$1012.55n/a−$26810.00
Q4 FY24−$646.80n/a−$61239.15
Q3 FY24$2563.05n/a−$176384.25
Q2 FY24−$27713.70n/a−$271954.20
Q1 FY24−$35441.70n/a−$431886.00
Q4 FY23−$115791.90n/a−$692796.30
Q3 FY23−$93006.90n/a−$835283.40

Against its peers

Companies in Medical - Devices nearest Nuwellis' size, closest first, today.

CompanyEPS, 12 months
NUWENuwellis−$136.54
NXLNexalin Technology−$14.40
NDRAENDRA Life Sciences−$5.99
IRIXIridex−$0.20
QTIQT Imaging−$1.57
POCIPrecision Optics−$0.46
ECORelectroCore−$1.66
HYPRHyperfine−$0.38
OMOutset Medical−$4.08
NRXSNeuraxis, INC−$0.79
VANIVivani Medical−$0.35
Peer median−$1.18

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Nuwellis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.